Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

1481 - 1490 of 5136 results found

Activation of PXR causes drug interactions with Paxlovid in transgenic mice

Date
Thursday, November 16, 2023 - 4:00 AM
Description
Paxlovid is a nirmatrelvir (NMV) and ritonavir (RTV) co-packaged medication used for the treatment of coronavirus disease 2019 (COVID-19). The active component of Paxlovid is NMV and RTV is a pharmacokinetic booster. Our work aimed to investigate the

Adjunctive treatment in COVID-19 and sepsis-What did we learn?

Date
Wednesday, November 15, 2023 - 4:00 AM
Description
The introduction of anakinra, baricitinib and tocilizumab into the treatment armamentarium of severe coronavirus disease 2019 (COVID-19) reinforced the concept of immunotherapy for bacterial sepsis. The current review investigates how the example of

Acquired immunity against SARS-CoV-2 infection and vaccination

Date
Wednesday, November 15, 2023 - 4:00 AM
Description
The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused more than 700 million confirmed infections and ~7 million fatalities worldwide since its emergence in December 2019. SARS-CoV-2 is part of a family of